Maven Securities’s Elevance Health ELV Stock Holding History

Maven Securities’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-694	Closed	-$290K	–	882
2024 Q3	$361K	Buy	+694	New	+$371K	0.01%	726
2024 Q2	–	Sell	-1,050	Closed	-$555K	–	927
2024 Q1	$544K	Buy	1,050 +394	+60%	+$196K	0.03%	208
2023 Q4	$309K	Buy	+656	New	+$303K	0.01%	806
2023 Q3	–	Sell	-4,051	Closed	-$1.84M	–	1110
2023 Q2	$1.8M	Buy	+4,051	New	+$1.87M	0.03%	312
2022 Q4	–	Sell	-5,566	Closed	-$2.83M	–	920
2022 Q3	$2.53M	Buy	+5,566	New	+$2.66M	0.05%	253
2021 Q3	–	Sell	-1,790	Closed	-$680K	–	1109
2021 Q2	$683K	Buy	+1,790	New	+$684K	0.03%	554
2021 Q1	–	Sell	-732	Closed	-$235K	–	1202
2020 Q4	$235K	Buy	+732	New	+$225K	0.02%	478
2020 Q3	–	Sell	-1,539	Closed	-$405K	–	639
2020 Q2	$405K	Buy	+1,539	New	+$411K	0.03%	351

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Maven Securities's ELV Position: Q4 2024 in Review

Maven Securities sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 694 shares — an estimated $290K sold.

Maven Securities first reported a position in ELV in Q2 2020 and held it in 8 quarters. The position peaked at $2.53M in Q3 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Maven Securities reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Maven Securities sold 694 Elevance Health shares in Q4 2024, an estimated $290K.
Maven Securities first reported a position in Elevance Health in Q2 2020 and held it in 8 quarters.
Maven Securities's Elevance Health position peaked at $2.53M in Q3 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.